Last reviewed · How we verify
Drug containing the active ingredient
At a glance
| Generic name | Drug containing the active ingredient |
|---|---|
| Also known as | Tyrosur® Gel |
| Sponsor | Engelhard Arzneimittel GmbH & Co.KG |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease (PHASE3)
- Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics (NA)
- The Effects of a Probiotic Food Supplement in Hyperuricaemia (NA)
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (PHASE2)
- Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer (PHASE2)
- A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (PHASE2)
- Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults (PHASE1)
- Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: